asalyxa-bio
Ann Arbor's Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech
Asalyxa Bio, Inc., a biopharmaceutical startup developing nano-engineered, immune cell-targeted therapeutics, just announced the closing of…
A New Anti-Inflammatory Treatment Could Aid Sickest COVID Patients
This post is sponsored by business support organization Ann Arbor SPARK, which promotes the growth and development of businesses in…